EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

L-theanine promotes angiogenesis in limb ischemic mice by modulating NRP1/VEGFR2 signaling

Jingyi Wang, Yinghui Xu, Yating Ruan, Xinyang Hu

Biomolecules and Biomedicine · 2025

DOI: 10.17305/bb.2024.11256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Jingyi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Cancer Hospital, Hangz…. Hauptthemen laut MEDLINE: Neuropilin-1, Vascular Endothelial Growth Factor Receptor-2, Signal Transduction, Glutamates. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral artery disease (PAD), primarily caused by atherosclerosis, leads to the narrowing or blockage of arteries that supply blood to the limbs. This study explores the pro-angiogenic effects of L-theanine and its underlying mechanisms in a mouse model of hindlimb ischemia (HLI). To evaluate L-theanine’s pro-angiogenic effects, human umbilical vein endothelial cells (HUVECs) were subjected to tube formation, migration, sprouting, and proliferation assays. In vivo, C57BL/6 mice with induced HLI were treated with L-theanine. Blood flow recovery was measured via Doppler ultrasound, and vascular density was analyzed using immunofluorescence staining. RNA sequencing identified neuropilin-1 (NRP1) as a key regulator, and the expression levels of NRP1 and VEGFR2 were examined through qPCR and Western blotting. L-theanine significantly enhanced angiogenesis in HUVECs, as demonstrated by improved tube formation, migration, sprouting, and proliferation. In mice, L-theanine treatment resulted in increased vessel density and improved blood flow recovery. Furthermore, L-theanine was found to activate the NRP1/VEGFR2 signaling pathway in both HUVECs and the HLI mouse model. These findings indicate that L-theanine can promote angiogenesis and activate key pathways involved in vascular repair, suggesting its potential as a therapeutic agent for treating vascular defects associated with PAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuropilin-1Vascular Endothelial Growth Factor Receptor-2Signal TransductionGlutamatesIschemiaHindlimbNeovascularization, PhysiologicAnimalsHuman Umbilical Vein Endothelial CellsHumansMiceMice, Inbred C57BLDisease Models, AnimalCell ProliferationMaleCell MovementAngiogenesis

Substanzen

Neuropilin-1theanineVascular Endothelial Growth Factor Receptor-2GlutamatesKdr protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Zhejiang Cancer Hospital, Hangzhou, China.
  • Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China; Cardiovascular Key Labor…

Zitieren

APA

Wang, J., Xu, Y., Ruan, Y., & Hu, X. (2025). L-theanine promotes angiogenesis in limb ischemic mice by modulating NRP1/VEGFR2 signaling. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.11256

Vancouver

Wang J, Xu Y, Ruan Y, Hu X. L-theanine promotes angiogenesis in limb ischemic mice by modulating NRP1/VEGFR2 signaling. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2024.11256

BibTeX
@article{Wang2025,
  author = {Wang, Jingyi and Xu, Yinghui and Ruan, Yating and Hu, Xinyang},
  title = {L-theanine promotes angiogenesis in limb ischemic mice by modulating NRP1/VEGFR2 signaling},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  doi = {10.17305/bb.2024.11256}
}
Kostenlos starten →